» Articles » PMID: 36969207

Attenuated Fecal Dysbiosis and Metabolome Changes in -administered Bilateral Nephrectomy Mice

Abstract

The impacts of metabolomic changes (reduced short-chain-fatty acids; SCFAs) in uremic condition is not fully understood. Once daily gavage with or without probiotics (different times of administration) for 1 week prior to bilateral nephrectomy (Bil Nep) in 8-week-old C57BL6 mice as the possible models more resemble human conditions were performed. -administered Bil Nep mice demonstrated more severe conditions than Bil Nep alone as indicated by mortality (n = 10/group) and other 48 h parameters (n = 6-8/group), including serum cytokines, leaky gut (FITC-dextran assay, endotoxemia, serum beta-glucan, and loss of Zona-occludens-1), and dysbiosis (increased with decreased diversity in microbiome analysis) (n = 3/group for fecal microbiome) without the difference in uremia (serum creatinine). With nuclear magnetic resonance metabolome analysis (n = 3-5/group), Bil Nep reduced fecal butyric (and propionic) acid and blood 3-hydroxy butyrate compared with sham and -Bil Nep altered metabolomic patterns compared with Bil Nep alone. Then, dfa1 (SCFA-producing ) (n = 8/group) attenuated the model severity (mortality, leaky gut, serum cytokines, and increased fecal butyrate) of Bil Nep mice (n = 6/group) (regardless of ). In enterocytes (Caco-2 cells), butyrate attenuated injury induced by indoxyl sulfate (a gut-derived uremic toxin) as indicated by transepithelial electrical resistance, supernatant IL-8, expression, and cell energy status (mitochondria and glycolysis activities by extracellular flux analysis). In conclusion, the reduced butyrate by uremia was not enhanced by administration; however, the presence of in the gut induced a leaky gut that was attenuated by SCFA-producing probiotics. Our data support the use of probiotics in uremia.

References
1.
Hiengrach P, Panpetch W, Chindamporn A, Leelahavanichkul A . , Protected from Antibiotics and Stresses Inside Vacuoles, Cause Gastritis in Mice. Int J Mol Sci. 2022; 23(15). PMC: 9368807. DOI: 10.3390/ijms23158568. View

2.
Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X . NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016; 7(20):29454-64. PMC: 5045409. DOI: 10.18632/oncotarget.8762. View

3.
Mitch W . Effects of intestinal flora on nitrogen metabolism in patients with chronic renal failure. Am J Clin Nutr. 1978; 31(9):1594-600. DOI: 10.1093/ajcn/31.9.1594. View

4.
Ondee T, Gillen J, Visitchanakun P, Somparn P, Issara-Amphorn J, Dang Phi C . Lipocalin-2 (Lcn-2) Attenuates Polymicrobial Sepsis with LPS Preconditioning (LPS Tolerance) in FcGRIIb Deficient Lupus Mice. Cells. 2019; 8(9). PMC: 6769833. DOI: 10.3390/cells8091064. View

5.
Panpetch W, Hiengrach P, Nilgate S, Tumwasorn S, Somboonna N, Wilantho A . Additional administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by L34. Gut Microbes. 2019; 11(3):465-480. PMC: 7527076. DOI: 10.1080/19490976.2019.1662712. View